New Year, New Us: Get A Sneak Peak At Our New Site


The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy.

RhoA/ROCK pathway participates in the study of related mechanisms of apatinib in the treatment of breast cancer-induced hypertension

Wenjuan Wang, Haodong zhang, Qiongying Wang, Chenchen Zhuang, Xin Fan, Caie Li, Runmin Sun, Miaomiao Qi

Metformin attenuates the cardiotoxicity of ibrutinib through AMPK and PI3K-Akt pathway

Pengsha Li, Ming Yuan, Daiqi Liu, Bingxin Xie, Guangping Li MD PhD, Gary Tse MD FRCP FACC, Tong Liu MD PhD FESC

A Novel Diagnostic Approach for the Detection of Cardiac Dysfunction from Breast Cancer Therapy Validation Study with Cardiovascular Magnetic Resonance

Maryam MD; Camila M. Urzua Fresno, MD; Emily Somerset MSc; Tamar Shalmon MD; Eitan Amir MD PhD; Chun-Po Steve Fan PhD; Christine Brezden-Masley MD, PhD; Babitha Thampinathan RDCS, Yobiga Thevakumaran RN; Kibar Yared MD; C. Anne Koch MD PhD; Husam Abdel-Qadir MD, PhD; Anna Woo, MD, SM; Paul Yip, PhD; Thomas H. Marwick MD, PhD, MPH; Rosanna Chan BSc; Bernd J. Wintersperger MD; Paaladinesh Thavendiranathan MD, SM

Can pyridoxamine tackle anthracycline-induced cardiotoxicity?

Sibren Haesen, Aline Brillouet, Iris de Laat, Lotte Vastmans, Lize Evens, Sarah D’Haese, Esther Wolfs, Dorien Deluyker, Virginie Bito

Blockade of the innate immune checkpoint CD47 decreases infarct size by modulation of oxidative stress and immune response

S. Korste, P. Stock, U. Hendgen-Cotta, T. Rassaf, M. Totzeck